Adagene

NASDAQ: ADAG
Uses Smart Antibody Technology to accelerate development and reduce costs in antibody discovery.
Uses Smart Antibody Technology to accelerate development and reduce costs in antibody discovery.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Suzhou, China

Initial Investment

2011
Adagene

Adagene (Nasdaq: ADAG) is an antibody discovery and engineering company with proprietary Smart Antibody Technology, which increases success rates, substantially accelerates time to market, and reduces the costs associated with developing a therapeutic antibody.